Why use it

Endorsed by ACC/AHA perioperative guidelines as the primary risk stratification tool for non-cardiac surgery. Simple, validated, and widely used in preoperative assessment. Guides decisions on perioperative beta-blockers, cardiac testing, and subspecialty consultation.

About

The Revised Cardiac Risk Index (RCRI) estimates the risk of major adverse cardiac events (MACE) — including myocardial infarction, pulmonary edema, ventricular fibrillation, cardiac arrest, and complete heart block — in patients undergoing non-cardiac surgery. It uses six independent clinical predictors to stratify patients into risk categories to guide perioperative cardiac evaluation and management.

When to use

Preoperative cardiac risk assessment for non-cardiac surgery
Decision on need for preoperative cardiac testing
Perioperative beta-blocker therapy planning
Subspecialty cardiology consultation decisions

Formula

1 point each (total 0–6): 1. High-risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular) 2. Ischemic heart disease (history of MI, positive stress test, chest pain due to CAD, nitrate use, Q waves on ECG) 3. History of congestive heart failure 4. History of cerebrovascular disease (stroke or TIA) 5. Insulin-dependent diabetes mellitus 6. Preoperative creatinine > 2.0 mg/dL

Pearls & pitfalls

The RCRI does not predict MI specifically — it predicts composite MACE including pulmonary edema and cardiac arrest.
RCRI does NOT include age or emergency surgery — the Gupta MICA score may be more accurate in some settings.
Beta-blocker continuation (not initiation) is recommended perioperatively in RCRI patients on chronic beta-blockade.
Suprainguinal aortic surgery and intrathoracic surgery are "high-risk" surgeries in the RCRI.
Elevated troponin post-operatively (myocardial injury after non-cardiac surgery, MINS) is common and prognostically important.
ACC/AHA 2014 perioperative guidelines recommend RCRI as first-line risk stratification tool.

Next steps

RCRI 0: Very low risk (~0.4%) — proceed to surgery. RCRI 1: Low risk (~0.9%) — proceed; beta-blockers if on chronic therapy. RCRI 2: Moderate risk (~6.6%) — cardiac testing if it will change management. RCRI ≥ 3: High risk (~>11%) — cardiac evaluation; consider noninvasive stress testing; optimize medical therapy.

Evidence

Lee et al. (Circulation 1999) derived RCRI from 4,315 patients undergoing elective non-cardiac surgery. External validation in multiple large datasets. AUC 0.74–0.82 for MACE prediction. Endorsed by ACC/AHA 2014 and 2022 perioperative guidelines.

References

Lee TH et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043-1049. — link
Fleisher LA et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. J Am Coll Cardiol. 2014;64(22):e77-e137. — link

Revised Cardiac Risk Index (RCRI)

Calculator